This topic contains a solution. Click here to go to the answer

Author Question: To promote innovation management one should A) remove all time constraints to discourage a sense ... (Read 66 times)

tth

  • Hero Member
  • *****
  • Posts: 579
To promote innovation management one should
 
  A) remove all time constraints to discourage a sense of urgency. B) carefully link goals to the corporate mission, but not so specific that they are restrictive. C) make it clearly understood that people who fail to produce will be replaced. D) implement a generous compensation system that directly rewards ones contributions to achieving the
  goals.

Question 2

The type of innovation that continues to improve an existing service or product, and has a minor impact on
  existing business, is called
 
  A) radical innovation. B) disruptive innovation. C) sustaining innovation. D) end-user innovation.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

mjbamaung

  • Sr. Member
  • ****
  • Posts: 343
Answer to Question 1

B

Answer to Question 2

C




tth

  • Member
  • Posts: 579
Reply 2 on: Jul 7, 2018
Wow, this really help


miss_1456@hotmail.com

  • Member
  • Posts: 289
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

During pregnancy, a woman is more likely to experience bleeding gums and nosebleeds caused by hormonal changes that increase blood flow to the mouth and nose.

Did you know?

There are more sensory neurons in the tongue than in any other part of the body.

Did you know?

In 1835 it was discovered that a disease of silkworms known as muscardine could be transferred from one silkworm to another, and was caused by a fungus.

Did you know?

Medication errors are three times higher among children and infants than with adults.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library